Form 4 for NVCR NovoCure Ltd
Accepted 2021-08-06 00:00:00 ET · period of report 2021-08-05 · accession 0001645113-21-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-06 | 2021-08-05 | NVCR | LEUNG GABRIEL | Dir | M - OptEx | $31.45 | +1,000 | 73.9K | +1% | +$31.4K |
| D | 2021-08-06 | 2021-08-05 | NVCR | LEUNG GABRIEL | Dir | S - Sale+OE | $152.50 | -1,000 | 72.9K | -1% | -$152.5K |
| D | 2021-08-06 | 2021-08-05 | NVCR | LEUNG GABRIEL | Dir | M - OptEx | $0.00 | -1,000 | 2,345 | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-05 | M | A | 1,000 | $31.45 | 73,859 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. |
| 2 | Common | Ordinary Shares | 2021-08-05 | S | D | 1,000 | $152.50 | 72,859 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. |
| 3 | Derivative | Options to Buy Ordinary Shares | 2021-08-05 | M | D | 1,000 | $0.00 | 2,345 | D | $31.45 · — to 2028-05-30 | 1,000 Ordinary Shares | (F2) Fully vested as of the date hereof. |